Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
ACADAcadia Pharmaceuticals	$3.98bn	43.22	n/a
RYZBRayzebio	$3.81bn	n/a	n/a
MTSRMetsera	$3.75bn	n/a	n/a
CBAYCymaBay Therapeutics	$3.73bn	n/a	n/a
PTGXProtagonist Therapeutics	$3.66bn	82.84	n/a
AKROAkero Therapeutics	$3.48bn	n/a	n/a
MLTXMoonLake Immunotherapeutics	$3.38bn	n/a	n/a
KYMRKymera Therapeutics	$3.36bn	n/a	n/a
CRNXCrinetics Pharmaceuticals	$3.20bn	n/a	n/a
SRRKScholar Rock Holding	$3.04bn	n/a	n/a
CNTACentessa Pharmaceuticals	$2.92bn	n/a	n/a
KDNYChinook Therapeutics	$2.90bn	n/a	n/a
MORFMorphic Holding	$2.86bn	n/a	n/a
SLNOSoleno Therapeutics	$2.85bn	n/a	n/a
IMVTImmunovant	$2.82bn	n/a	n/a
MLYSMineralys Therapeutics	$2.80bn	n/a	n/a
XENEXenon Pharmaceuticals	$2.79bn	n/a	n/a
VKTXViking Therapeutics	$2.79bn	n/a	n/a
NAMSNewAmsterdam Pharma NV	$2.72bn	n/a	n/a
CGONCG Oncology	$2.54bn	n/a	n/a